-+ 0.00%
-+ 0.00%
-+ 0.00%

Bruker Projects Q2 Revenue Of $795M–$798M; Non-GAAP EPS Expected At $0.32–$0.34, Down $0.19 YoY Amid $0.06 FX Impact

Benzinga·07/21/2025 14:59:24
Listen to the news

Bruker Corporation (NASDAQ:BRKR) today announced preliminary revenue for the second quarter ended June 30, 2025 in a range of $795 - $798 million, which implies approximately flat reported revenue year-over-year. Bruker estimates that its non-GAAP organic revenue in the second quarter of 2025 declined approximately 7% year-over-year, with constant-exchange rate revenue declining approximately 3%.

Second quarter 2025 bookings reflect weak academic demand, as well as softness in the U.S. biopharma market. Second quarter 2025 non-GAAP EPS is expected in the $0.32 - $0.34 range, representing approximately a $0.19 per share decline year-over-year, including a $0.06 foreign currency headwind.